Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (CelerisTx One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices.
CelerisTx's drug pipeline is focused on CNS and oncology, targeting unmet medical needs. We also co-develop therapeutics with pharmaceutical and biotech companies.
CelerisTx has so far attracted a total of EUR 18 million in committed capital from venture capital funds, which include EIC Fund, Pace Ventures Enigma, i&i biotech, Apex Ventures, R42 and longevitytech.fund.
#targetedproteindegradation #degrader #ubiquitinproteasomesystem #machinelearning #CelerisOne #proximityinducingcompounds #PICs
Company Details
- Founded
- -
- Address
- Glenwood Ave, Menlo Park,kalifornien 94025,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://celeristx.com
- Keywords
- PROTAC, Molecular glue, Deep Learning, Geometric Deep Learning, Protein, PPI, Protein-Protein-Interaction, Artificial Intelligence, Drug Builder, Drug Discovery, Drug Design, Protein-Ligand Interaction, Graph Neural Networks.
- HQ
- Menlo Park, Kalifornien
Celeris Therapeutics Questions
Celeris Therapeutics's website is https://celeristx.com
Celeris Therapeutics's LinkedIn profile is https://www.linkedin.com/company/celeristx
Celeris Therapeutics's industry is
Pharmaceutical Manufacturing
Celeris Therapeutics's top competitors are
Olden Labs,
Yuri,
Venga Ventures,
Atmos Space Cargo,
Apex Ventures,
Ternary Therapeutics,
Rdp Pharma Ag,
Adhesion Therapeutics,
Biotech Austria,
Ai|ffinity.
Celeris Therapeutics's categories are Pharmaceutical Manufacturing
Celeris Therapeutics's founding year is 2021
